The impact of early adequate antimicrobial therapy on 14-day mortality in patients with monomicrobial Pseudomonas aeruginosa and Acinetobacter baumannii bacteremia.

Abstract

The impact of colistin therapy for early adequate antimicrobial therapy on clinical outcomes has rarely been evaluated in patients with Pseudomonas aeruginosa bacteremia (PAB) or Acinetobacter baumannii bacteremia (ABB). We investigated the impact of early adequate antimicrobial therapy on 14-day mortality in 149 patients with monomicrobial PAB and ABB at… (More)
DOI: 10.1007/s10156-013-0571-3

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.